1 |
Kulcsar KA, Coleman CM, Beck SE, et al. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection[J]. JCI Insight, 2019, 4(20): 1317-1320.
|
2 |
刘 璐,赖 倩. 雾化吸入布地奈德治疗AECOPD合并2型糖尿病患者疗效及对肺通气功能和糖代谢的影响[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(4): 427-430.
|
3 |
Filardi T, Morano S. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes[J]. J Endocrinol Invest, 2020, 43(8): 1053-1060.
|
4 |
朱 燕,卢曙芳,斯浣菲,等. 糖尿病并发肺部感染患者的临床研究[J]. 中国预防医学杂志,2020, 21(10): 33-37.
|
5 |
李 静,罗恒聪,熊明媚,等. 重症肺部感染对2型糖尿病患者凝血与纤溶机制的影响[J]. 中华医院感染学杂志,2019, 29(6): 839-842.
|
6 |
Franquet T. Imaging of community-acquired pneumonia[J]. J Thorac Imaging, 2018, 33(5): 282-294.
|
7 |
赵红梅,彭志毅,江 鑫,等. Ⅱ型糖尿病合并肺部感染患者感染及影像学特点分析[J]. 中华医院感染学杂志,2019, 29(7): 1038-1041.
|
8 |
Liu GB, Cui XQ, Wang ZB, et al. Detection of serum procalcitonin and hypersensitive C-reactive protein in patients with pneumonia and sepsis[J]. J Biol Regul Homeost Agents, 2018, 32(5): 1165-1169.
|
9 |
林国辉,孙瑞琳,王 燕,等. 淀粉样蛋白A和超敏C-反应蛋白与血清降钙素原对原发性肺癌患者肺部感染的诊断效果[J]. 中华医院感染学杂志,2020, 30(2): 30-33.
|
10 |
Velasco-Arnaiz E, Perez E, Henares D, et al. Use of procalcitonin in the diagnosis of tuberculosis in infants and preschool children[J]. Eur J Pediatr, 2018, 177(9): 1377-1381.
|
11 |
王家富,李 放,安术祥,等. 血清PCT及sTREM-1在肺癌术后并发细菌性肺部感染的诊断价值[J]. 中华医院感染学杂志,2019, 29(9): 1374-1378.
|
12 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志,2018, 10(1): 4-67.
|
13 |
中国医师协会急诊医师分会,中国急性感染联盟. 2015年中国急诊社区获得性肺炎临床实践指南[J].中华急诊医学杂志,2015, 24(12): 1324-1344.
|
14 |
Wijnant SRA, Jacobs M, Van Eeckhoutte HP, et al. Expression of ACE2, the sars-CoV-2 receptor, in lung tissue of patients with type 2 diabetes[J]. Diabetes, 2020, 69(12): 2691-2699.
|
15 |
Chumburidze-Areshidze N, Kezeli T, Avaliani Z, et al. The relationship between type-2diabetes and tuberculosis[J]. Georgian Med News, 2020, 3(300): 69-74.
|
16 |
云 川,陈小盼,韩倩菲,等. 维生素D缺乏程度与2型糖尿病患者合并肺部感染相关性分析[J]. 临床军医杂志,2019, 47(6): 601-602.
|
17 |
George C, Ducatman AM, Conway BN. Increased risk of respiratory diseases in adults with Type 1 and Type 2 diabetes[J]. Diabetes Res Clin Pract, 2018, 1(142): 46-55.
|
18 |
王卓亚,杨发满,刘 冀,等. 老年糖尿病合并肺部感染患者的药学观察[J]. 重庆医学,2018, 47(6): 816-818.
|
19 |
郗 颖,曾 佳,翟连臣. 糖尿病合并肺部感染患者纤维蛋白原与抗apoA-1IgG及NLR的研究[J]. 中华医院感染学杂志,2020, 30(3): 40-43.
|
20 |
Abedini A, Kiani A, Emami H, et al. Serum procalcitonin level as a predictor of bacterial infection in patients with COPD exacerbation[J]. Tanaffos, 2019, 18(2): 112-117.
|
21 |
Sproston NR, Ashworth JJ. Role of C-Reactive protein at sites of inflammation and infection[J]. Front Immunol, 2018, 13(9): 754-757.
|
22 |
崔晓婷,郑红晓,李海燕,等. 血清BNP与hs-CRP和PCT对慢性心力衰竭患者肺部感染的诊断评价[J]. 中华医院感染学杂志,2019, 29(11): 1651-1655.
|
23 |
Choi JJ, McCarthy MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27-34.
|
24 |
叶 彬,郝 群,茹小虎,等. 肺癌患者术后肺部感染sTREM-1和sCD163与PCT变化研究[J]. 中华医院感染学杂志,2019, 29(11): 1673-1676.
|
25 |
Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing[J]. J Med Virol, 2020, 92(7): 797-806.
|
26 |
Yao Z, Zhang Y, Wu H. Regulation of C-reactive protein conformation in inflammation[J]. Inflamm Res, 2019, 68(10): 815-823.
|